期刊文献+

G实验和真菌培养在艾滋病人深部真菌感染中的联合诊断 被引量:4

Combined diagnosis of G-test and fungal culture in deep fungus infection for AIDS
下载PDF
导出
摘要 目的:探讨血清(1-3)-β-D葡聚糖对艾滋病人深部真菌感染的早期诊断.方法:对2014年1月~2014年3月入住我院的68例疑为深部真菌感染的艾滋病人,进行血清(1-3)-β-D葡聚糖检测,并与真菌培养加以对比及结合,观察其在深部真菌感染中的诊断价值.结果:68例疑为深部真菌感染的艾滋病患者,血清(1-3)-β-D葡聚糖阳性率为91.5%,而真菌培养的阳性率仅为57.8%,血清(1-3)-β-D葡聚糖检测阳性率明显高于真菌培养(x2=0.96,P<0.05).血清(1-3)-β-D葡聚糖检测与真菌培养相结合,灵敏度、特异度以及阳性预测值和阴性预测值比单独血清(1-3)-β-D葡聚糖检测或真菌培养阳性率高.结论:血清(1-3)-β-D葡聚糖检测能更早、更灵敏反应深部真菌早期感染;将其与真菌培养结合,能提高深部真菌感染的诊断率. Objective: To evaluate(1-3)-β-D glucan for early diagnosis of fungal infections in AIDS. Methods. (1-3)-β-D glucan were quantitative detected in 68 AIDS cases who suspected deep fungus infection in our hospital during Jan to Mar, 2014. Combined with fungal culture comparisons and observed value in diagnosis of fungal infections. Results: 68 AIDS case of suspected deep fungus infection, the positive rate of (1-3)-β-D glucan and fungal culture were 91.5% and 57.8%. The positive rate of(1-3)-β-D glucan was significantly higher than fungal culture(X2 =0. 96, P〈0. 05). Compared with individual(1-3)-β-D glucan or fungal culture, the sensitivity, specificity, positive predictive value and negative predictive value are higher in(1-3)-β-D glucan combined with fungal culture. Conclusion. (1-3)-β-D glucan is much earlier and more sensitive than fungal culture in early application in deep fungus infection. Combined(1-3)-β-D glucan and fungal culture can improve the rate of diagnosis of deep fungal infection.
出处 《四川生理科学杂志》 2014年第4期173-175,共3页 Sichuan Journal of Physiological Sciences
关键词 深部真菌感染 血清(1-3)-β-D葡聚糖 真菌培养 Infection of deep fungus (1-3)-β-D glucan Fungal culture
  • 相关文献

参考文献8

二级参考文献54

  • 1熊祝嘉,徐英春.半乳甘露聚糖用于侵袭性曲霉感染实验诊断的研究现状[J].中国真菌学杂志,2007,2(1):52-54. 被引量:9
  • 2乐杰.妇产科学(第4版)[M].北京:人民卫生出版社,1998.115.
  • 3[3]Baselski V, Mason K. Pneumonia in the immunocompromised host: the role of brochoscopy and newer diagnostic techniques [J]. Semin Respir, 2000,15:144-161
  • 4[4]Erasmus JJ, McAdams HP, Rossi S, et al. Percutaneous management of intrapulmonary air and fluid collections [J]. Radiol Clin North Am, 2000,38: 385-393
  • 5[7]Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungai infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus [J]. Clin Infect Dis, 2002,34:7-14
  • 6[8]Loeffler J, Stevens DA. Antifungal drug resistance [J]. Clin Infect Dis, 2003, 36 (suppl 1): S31-41
  • 7[9]Whit MH, Anaissie EJ, Kusne S, et al. Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis [J]. Clin Inf Dis, 1997,24: 635-642
  • 8[10]Bellmann R, Egger P, Wiedermann CJ. Differences in pharmacokinctics of amphotericin B lipid formulations despite clinical equivalence [J]. Clin Infect Dis, 2003,36:1500-1501
  • 9[12]Hitchcock CA, Pye GW, Oliver GP, et al. UK-109, 496: a novel, wide-spectrum triazol derivative for the treatment of fungal infection: antifungal activity and selectivity in vitro. In: Microbiology Asf. 35th Intersciences Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, 1995
  • 10[13]Murphy M, Bernard EM, Ishimaru T, et al. Activity of voriconazol (UK-109, 496) against clinical isolates of Aspergillus species and its effectiveness in an experimental of invasive pulmonary aspergillosis[J]. Antimicrob Agents Chemother 1997,41: 696-698

共引文献122

同被引文献39

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部